Clinical Trial Update: A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1 study of SHR-A1811 in patients with HER2-expressing tumors, including gastric cancer and colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gastric Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED